Celecoxib for recurrent sclerouveitis after syphilitic panuveitis. A case report

PURPOSE: To report a case of recurrent ocular inflammation after optimal therapy of bilateral syphilitic panuveitis responding to oral celecoxib. METHODS: A case report was conducted. RESULTS: A 76-year-old man presented with painful blurry vision in both eyes. Ocular examination disclosed bilateral...

Descripción completa

Detalles Bibliográficos
Autores principales: Suelves, Ana M., Martinez-Castillo, Sebastián, Salavert, Miguel, Díaz-Llopis, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223351/
https://www.ncbi.nlm.nih.gov/pubmed/21785853
http://dx.doi.org/10.1007/s12348-011-0031-0
Descripción
Sumario:PURPOSE: To report a case of recurrent ocular inflammation after optimal therapy of bilateral syphilitic panuveitis responding to oral celecoxib. METHODS: A case report was conducted. RESULTS: A 76-year-old man presented with painful blurry vision in both eyes. Ocular examination disclosed bilateral panuveitis. Serological testing confirmed blood and cerebrospinal fluid syphilitic involvement. After 2 weeks of intravenous penicillin therapy, recurrent episodic sclerouveitis was observed. CONCLUSION: Ocular inflammation after healing of infectious uveitis is a rare ophthalmic sequela. In an immunocompetent patient, either re-infection or immune uveitis should be evoked. Non-steroidal therapeutic options, as celecoxib, could be a good option of treatment in such immune cases.

Ejemplares similares